2m 2m 2m 2m 2m 2m 2m
AC IMMUNE N (ACIU)
NASDAQ
$2.44+$0.02 (+0.83%)
Price as of Jun 03, 2026 7:28 PM EDT- $292.9MMarket Cap
- 46.67%1-Year Change
- BiotechnologyIndustry
AC IMMUNE N (ACIU)
$2.44+$0.02 (+0.83%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.6M -86.92% | 27.3M +84.51% | 14.8M +276.14% | 3.9M N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 3.6M -86.92% | 27.3M +84.51% | 14.8M +276.14% | 3.9M N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -56.4M -9.80% | -62.6M +14.58% | -54.6M -9.50% | -60.3M -3.12% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 16.1M -6.75% | 17.3M +12.77% | 15.3M -3.07% | 15.8M -11.84% | |
Operating Profit | -69.3M +32.34% | -52.4M -2.32% | -53.6M -24.31% | -70.8M -10.33% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | -70.4M +38.36% | -50.9M -6.12% | -54.2M -23.35% | -70.8M -3.07% | |
Income Taxes | 0 -100.00% | 3,000 -70.00% | 10,000 -23.08% | 13,000 +333.33% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -70.4M +38.36% | -50.9M -6.12% | -54.2M -23.35% | -70.8M -3.07% | |
Net Income from Continuing Operations Applicable to Common | -70.4M +38.36% | -50.9M -6.12% | -54.2M -23.35% | -70.8M -3.07% | |
Basic EPS and Net Income | -0.70 +37.25% | -0.51 -20.31% | -0.64 -24.71% | -0.85 -12.37% | |
Diluted EPS and Net Income | -0.70 +37.25% | -0.51 -20.31% | -0.64 -24.71% | -0.85 -12.37% | |
Basic Weighted Average Shares | 100.8M +1.06% | 99.7M +17.71% | 84.7M +1.36% | 83.6M +11.48% | |
Diluted Weighted Average Shares | 100.8M +1.06% | 99.7M +17.71% | 84.7M +1.36% | 83.6M +11.48% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 26.8M -26.13% | 36.3M -53.79% | 78.5M +148.51% | 31.6M -61.58% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 26.8M -26.13% | 36.3M -53.79% | 78.5M +148.51% | 31.6M -61.58% | |
Total Current Assets | 96.7M -43.76% | 172.0M +37.43% | 125.2M -2.30% | 128.1M -36.79% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 2.0M -24.97% | 2.7M -21.48% | 3.4M -20.73% | 4.3M -16.75% | |
Total Long-Term Assets | 57.5M -2.36% | 58.9M +2.18% | 57.7M -0.32% | 57.8M -1.64% | |
Total Assets | 154.3M -33.20% | 230.9M +26.31% | 182.8M -1.68% | 185.9M -28.88% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 94.7M -6.09% | 100.8M +642.77% | 13.6M +18.25% | 11.5M -42.67% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 14.7M -17.58% | 17.8M +107.16% | 8.6M +57.24% | 5.5M -42.09% | |
Total Liabilities | 109.4M -7.82% | 118.6M +435.13% | 22.2M +30.83% | 16.9M -42.48% | |
Retained Earnings | -439.0M +19.22% | -368.2M +16.46% | -316.2M +19.76% | -264.0M +31.39% | |
Total Stockholders Equity | 44.9M -60.02% | 112.3M -30.11% | 160.6M -4.94% | 169.0M -27.15% | |
Total Shares Outstanding | 101.7M +1.33% | 100.4M -3.86% | 104.4M +16.26% | 89.8M +7.61% | |
Cash Flow | |||||
Cash from Operating Activities | -69.3M -205.19% | 65.8M +209.00% | -60.4M -17.89% | -73.6M +11.99% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 63.5M +160.35% | -105.3M -260.39% | 65.6M +176.25% | 23.8M +144.28% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.0M -8.93% | -1.1M -102.59% | 43.3M +3,313.22% | -1.3M -103.30% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,940.05% +911.51% | -191.80% -47.06% | -362.30% -79.88% | -1,800.43% N/A | |
Return on Assets | -36.58% +48.62% | -24.61% -16.32% | -29.41% -7.00% | -31.63% +8.37% | |
Return on Equity | -89.65% +140.27% | -37.31% +13.40% | -32.90% -6.76% | -35.29% +8.16% | |
Revenue Growth | -86.92% -202.85% | 84.51% -69.40% | 276.14% N/A | N/A N/A | |
Current Ratio | 1.02 -40.11% | 1.71 -81.50% | 9.22 -17.37% | 11.16 +10.26% | |
Cash Ratio | 0.28 -21.32% | 0.36 -93.78% | 5.78 +110.16% | 2.75 -32.99% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow